Search Results - "Kemos, Polychronis"

Refine Results
  1. 1
  2. 2

    Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease by Alazawi, William, Bernabe, Eduardo, Tai, David, Janicki, Tomasz, Kemos, Polychronis, Samsuddin, Salma, Syn, Wing-Kin, Gillam, David, Turner, Wendy

    Published in PloS one (08-12-2017)
    “…Non-alcoholic fatty liver disease (NAFLD) has a bidirectional association with metabolic syndrome. It affects up to 30% of the general population, 70% of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Patient perspectives of artificial intelligence as a medical device in a skin cancer pathway by Kawsar, Anusuya, Hussain, Khawar, Kalsi, Dilraj, Kemos, Polychronis, Marsden, Helen, Thomas, Lucy

    Published in Frontiers in medicine (16-11-2023)
    “…The use of artificial intelligence as a medical device (AIaMD) in healthcare systems is increasing rapidly. In dermatology, this has been accelerated in…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Accuracy of an artificial intelligence as a medical device as part of a UK-based skin cancer teledermatology service by Marsden, Helen, Kemos, Polychronis, Venzi, Marcello, Noy, Mariana, Maheswaran, Shameera, Francis, Nicholas, Hyde, Christopher, Mullarkey, Daniel, Kalsi, Dilraj, Thomas, Lucy

    Published in Frontiers in medicine (2024)
    “…An artificial intelligence as a medical device (AIaMD), built on convolutional neural networks, has demonstrated high sensitivity for melanoma. To be of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer by Papachristos, Apostolos, Kemos, Polychronis, Kalofonos, Haralabos, Sivolapenko, Gregory

    Published in The oncologist (Dayton, Ohio) (01-10-2020)
    “…Background Bevacizumab treatment is subject to large interpatient variability in efficacy, which may partly be explained by differences in complex bevacizumab…”
    Get full text
    Journal Article
  11. 11

    BT03 (P63) Effectiveness of an image-analysing artificial intelligence-based digital health technology to diagnose nonmelanoma skin cancer and benign skin lesions by Marsden, Helen, Palamaras, Ioulios, Kemos, Polychronis, Greenhalgh, Jack

    Published in British journal of dermatology (1951) (26-06-2023)
    “…Abstract Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are common types of nonmelanoma skin cancer (NMSC). The DERM-003 study was a prospective…”
    Get full text
    Journal Article
  12. 12

    P63 Effectiveness of an image-analysing artificial intelligence-based digital health technology to diagnose nonmelanoma skin cancer and benign skin lesions by Marsden, Helen, Palamaras, Ioulios, Kemos, Polychronis, Greenhalgh, Jack

    Published in British journal of dermatology (1951) (26-06-2023)
    “…Abstract Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are common types of nonmelanoma skin cancer (NMSC). The DERM-003 study was a prospective,…”
    Get full text
    Journal Article
  13. 13

    The Risk of Venous Thromboembolism in Children With Inflammatory Bowel Disease by Harvey, Philip R, McNulty, David, Coupland, Benjamin, Kemos, Polychronis, Croft, Nicholas M, Trudgill, Nigel J

    Published in Inflammatory bowel diseases (14-11-2024)
    “…Abstract Background Recent studies of children with inflammatory bowel disease (IBD) demonstrate an increased venous thromboembolism (VTE) risk. However,…”
    Get full text
    Journal Article
  14. 14

    VEGF-A polymorphisms affect the pharmacologic effect of bevacizumab on VEGF-A levels in patients with metastatic colorectal cancer by Papachristos, Apostolos, Kemos, Polychronis, Kalofonos, Haralabos, Sivolapenko, Gregory

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e15505 Background: Bevacizumab treatment presents large interpatient variability in efficacy. Mutations in VEGF-A rs699947 are associated with…”
    Get full text
    Journal Article
  15. 15

    In Reply by Papachristos, Apostolos, Kemos, Polychronis, Kalofonos, Haralabos, Sivolapenko, Gregory

    Published in The oncologist (Dayton, Ohio) (01-12-2020)
    “…This letter to the editor responds to Le Louedec et al. regarding the recently published article on the correlation between bevacizumab exposure and survival…”
    Get full text
    Journal Article
  16. 16

    In Reply by Papachristos, Apostolos, Kemos, Polychronis, Kalofonos, Haralabos, Sivolapenko, Gregory

    Published in The oncologist (Dayton, Ohio) (01-12-2020)
    “…This letter to the editor responds to Le Louedec et al. regarding the recently published article on the correlation between bevacizumab exposure and survival…”
    Get full text
    Journal Article
  17. 17

    In Reply by Papachristos, Apostolos, Kemos, Polychronis, Kalofonos, Haralabos, Sivolapenko, Gregory

    Published in The oncologist (Dayton, Ohio) (26-10-2020)
    “…This letter to the editor responds to Le Louedec et al. regarding the recently published article on the correlation between bevacizumab exposure and survival…”
    Get full text
    Journal Article
  18. 18

    Socioeconomic Factors Associated With Liver-Related Mortality From 1985 to 2015 in 36 Developed Countries by Li, Wenhao, Kemos, Polychronis, Salciccioli, Justin D., Marshall, Dominic C., Shalhoub, Joseph, Alazawi, William

    Published in Clinical gastroenterology and hepatology (01-08-2021)
    “…There is increasing disparity in liver-related mortality worldwide. Although there are many biologic and lifestyle risk factors for liver-related mortality,…”
    Get full text
    Journal Article
  19. 19
  20. 20